Pantheon related stories
All articles and analysis
Side Letter: LPs' yen dilemma; Pantheon's wealth hires; PE's compliance costCurrency depreciation is causing headaches for Japanese LPs. Plus: Pantheon has made two wealth hires and why compliance staff are worth their weight in gold. Here's today's brief, for our valued subscribers only.
Side Letter: IR's evolving demands; UK's ethics encouragement; Hg's tech talkRegulatory complexity, digestible data and speed-dating were topics du jour at Wednesday's PEI Investor Relations, Marketing & Communications Forum. Plus: The UK government wants private equity to invest ethically; and Hg's head of research weighs in on today's tech climate. Here's today's brief, for our valued subscribers only.
Roundtable: How co-investors are adjusting to an unsettled marketInstitutional capital continues to flow into the co-investment market. With inflation high, interest rates on the rise and regulatory change on the horizon, managers need to work hard on returns.
Pantheon: 'Only top-performing managers make the cut for our investment trust'In its 35th year of operations, Pantheon International Plc's Helen Steers tells PEI what the investment fund looks for in a fund manager.
Side Letter: Insight's top tech tips; Hermes eyes GP-leds; ESG's liability loadAn Insight Partners veteran shares advice for companies hoping to weather the coming storm. Plus: Hermes GPE is bullish on secondaries; and why some believe the SEC's ESG disclosure rules are "screwed up". Here's today's brief, for our valued subscribers only.
Side Letter: Future Fund's reshuffle; PE's deal delays; Iowa's allocation issuesFuture Fund has rejigged its investment leadership model to prepare for macro turmoil. Plus: A labour shortage among private equity service providers is causing deal delays; and an Iowa pension is grappling with the denominator effect. Here's today's brief, for our valued subscribers only.
CHART: The biggest dedicated life sciences capital raisersDedicated life sciences firms with strong AUM growth have been prime targets for larger GPs recently – here's a list of firms ranked by capital raised.
PEI 300 2022: Fund of funds specialists evolveDue to their ongoing capital-raising efforts across various direct strategies, firms active in funds of funds continue to make the PEI 300.
Side Letter: First-time funders; Pantheon's $1bn milestone; Norway's climate enthusiastIt's the cusp of the Easter long weekend. We'll be back on Tuesday – in the meantime here's today's brief, for our valued subscribers only.
Side Letter: Ham Lane's token tie-up; TPG's climate close; Vitruvian's moonshotHamilton Lane is the latest private markets giant to acknowledge the exciting potential of private equity tokenisation. Plus: TPG is nearing its climate fund hard-cap and Vitruvian has acquired a stake in fundraising platform Moonfare. Here's today's brief, for our valued subscribers only.